Kinnate Biopharma Inc.
Kinnate Biopharma Inc. (KNTE) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
knte · market cap & enterprise value · FMP · as of Apr 2, 2024
Core market cap & key metrics
As of Apr 2, 2024, Kinnate Biopharma Inc. (KNTE) has a market cap — also referred to as its net worth or valuation — of $124,990,960, making it one of the top most valuable companies globally. Market Cap = $2.65 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Kinnate Biopharma Inc. (KNTE) has a market cap — also referred to as its net worth or valuation — of $124,990,960 as of Apr 2, 2024, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Kinnate Biopharma Inc. reached its all-time high market cap of $1.7B on Dec 31, 2020. Comparing the Kinnate Biopharma Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Kinnate Biopharma Inc. net worth vs peers and ask how Kinnate Biopharma Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
KNTE market cap · 6 questionsKinnate Biopharma Inc.'s net worth — measured as market capitalization — is $124,990,960 as of Apr 2, 2024. It ranks #0 globally. Market Cap = $$2.65 (price) × shares outstanding.